Did a change of glucagon derail the Inreda artificial pancreas trial?
Inreda’s recent year long study on their dual hormone AID system didn’t produce the results anyone wanted. Here we dig into that further.
Inreda’s recent year long study on their dual hormone AID system didn’t produce the results anyone wanted. Here we dig into that further.
Following Dexcom’s recent “Terms Update Debacle”, Diabettech took a a deep dive into what happened, what it means, and whether some of the content of recent updates to terms run counter to the overarching rules about personal health data in various jurisdictions.
Following the side by side evaluation of the various algorithms on 1 minute sensors with different decision cadence, this is what happened when I took it in-vivo and allowed those different cadences to run with a proper feedback loop.
As we saw more an more manufacturers attempting to bring patch pumps to the market, I felt it was time to look at some of the mechanical design challenges that they face, and how those affect their ability to deliver treatment.
As various presentations of Lyumjev are withdrawn across Europe, we take a deep dive into what lies behind the commercial reasons that Lilly has stated.
Copyright © 2026 | WordPress Theme by MH Themes